Rare CHI patients have been reported with elevated beta-hydroxybutyrate; some without further explanatory details; some with PGM1-mutations and fasting ketotic hypoglycemia but post-prandial hypoketotic CHI; and others with ketotic hypoglycemia during ongoing diazoxide treatment (27–29). Here, PGM1 is linked to Hypoglycemia.